News and Events

Tackling the barriers to rare disease insight

Addressing Real-Life Needs

Often, the most debilitating and insidious aspects of a rare disease are the ways it can threaten not just patients’ sense of identity, but also affect the community and people around them. Biopharma brands are in a unique position to support wraparound services by creating content and experiences that address the real-life, everyday needs of patients and the community they live in. As sponsors and publishers, biopharma can produce content that is rich, meaningful, and sustainable.

Taking a Content-Centric Approach

The COVID-19 pandemic has forced biopharma to shift en mass marketing to a more content-centric approach. The change is profound. This means we are now able to give customers uniquely relevant content when they want it and how they want to receive it. We can deliver hyper-relevant content that helps them live their lives as unique individuals while also bringing greater awareness and empathy to the communities. To improve engagement, we foresee content-centric marketing to alter the landscape.

A version of this article appeared in PharmaVoice.

Couple Walking

Unlocking Hope for Patients with Rare Diseases

CEO David Ormesher has hope for the future of rare diseases. Read about how data science and digital transformation will unlock new drugs for patients.

Read more
Older female on a virtual call with doctor

How patient services are redefining the patient relationship

For pharma leadership trying to define “digital transformation,” I would suggest that marketing is a great place to start the journey.

Read more
HCP looking at report

Restoring Growth

Since mid-March, biopharma marketers have scrambled to balance the need to protect their employees, especially their field sales force, while maintaining some semblance of relevant share of voice in the market.

Read more

Letʼs work together.